Oak Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.3M | Buy |
|
|||||
|
2025
Q1 | $10.3M | Buy |
|
|||||
|
2024
Q4 | $10.6M | Sell |
|
|||||
|
2024
Q3 | $13.7M | Buy |
|
|||||
|
2024
Q2 | $8.38M | Hold |
|
|||||
|
2024
Q1 | $8.31M | Hold |
|
|||||
|
2023
Q4 | $8.62M | Sell |
|
|||||
|
2023
Q3 | $10.5M | Sell |
|
|||||
|
2023
Q2 | $11.7M | Sell |
|
|||||
|
2023
Q1 | $13.1M | Buy |
|
|||||
|
2022
Q4 | $14.9M | Sell |
|
|||||
|
2022
Q3 | $14.1M | Buy |
|
|||||
|
2022
Q2 | $16.9M | Buy |
|
|||||
|
2022
Q1 | $15.9M | Buy |
|
|||||
|
2021
Q4 | $16.8M | Buy |
|
|||||
|
2021
Q3 | $12.2M | Buy |
|
|||||
|
2021
Q2 | $11.1M | Sell |
|
|||||
|
2021
Q1 | $11.4M | Sell |
|
|||||
|
2020
Q4 | $19.2M | Sell |
|
|||||
|
2020
Q3 | $20.8M | Sell |
|
|||||
|
2020
Q2 | $19.8M | Sell |
|
|||||
|
2020
Q1 | $20.1M | Sell |
|
|||||
|
2019
Q4 | $26.2M | Sell |
|
|||||
|
2019
Q3 | $24.8M | Sell |
|
|||||
|
2019
Q2 | $30.1M | Buy |
|
|||||
|
2019
Q1 | $28.9M | Sell |
|
|||||
|
2018
Q4 | $30.7M | Buy |
|
|||||
|
2018
Q3 | $30.8M | Buy |
|
|||||
|
2018
Q2 | $7.45M | Buy |
|
|||||
|
2018
Q1 | $7.29M | Buy |
|
|||||
|
2017
Q4 | $1.26M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $201K | Hold |
|
|||||
|
2015
Q4 | $219K | Sell |
|
|||||
|
2015
Q3 | $3.39M | Buy |
|
|||||
|
2015
Q2 | $3.17M | Buy |
|
|||||
|
2015
Q1 | $3.09M | Buy |
|
|||||
|
2014
Q4 | $2.67M | Hold |
|
|||||
|
2014
Q3 | $2.53M | Hold |
|
|||||
|
2014
Q2 | $2.54M | Hold |
|
|||||
|
2014
Q1 | $2.75M | Hold |
|
|||||
|
2013
Q4 | $2.63M | Buy |
|
|||||
|
2013
Q2 | $2.45M | Buy |
|